GENEVA, May 4 -- AC IMMUNE SA (EPFL Innovation Park, Building B1015 Lausanne) filed a patent application (PCT/GR2025/050031) for "COMPOUNDS FOR USE AS NEUROPROTECTIVE AGENTS AND/OR IN INHIBITING FORMATION OF ALPHA-SYNUCLEIN AGGREGATES" on Oct 24, 2025. With publication no. WO/2026/087909, the details related to the patent application was published on Apr 30, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TSIKA, Elpida (c/o AC Immune SAEPFL Innovation Park, Building B1015 Lausanne), DREYFUS, Nicolas Jacques Francois (c/o AC Immune SAEPFL Innovation Park, Building B1015 Lausanne), BHAWNANI, K...